Voreloxin

vosaroxin · Sunesis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Voreloxin, covering 2017-06-28 to 2018-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans [Phase 1, Phase 2]

See pricing